Wuhan Xinsheng Biotechnology Co., LTD

Wuhan Xinsheng Biotechnology Co., Ltd. is located in Zhongke Kaiwu Industrial Park, East Lake High-tech Development Zone, Wuhan City. It is a high-tech company that uses microfluidic technology to develop various testing products.

The core technology "microfluidic chip technology" mastered by Wuhan Xinsheng Biotechnology Co., Ltd. is a cutting-edge technology in the field of international biomedical engineering. Since its establishment, the company has been committed to the research and development and independent innovation of microfluidic chip technology, and has obtained a number of independent intellectual property rights in this field.

Based on the field of in vitro diagnostics, Xinsheng uses the world's leading microfluidic technology to develop biochemical and immunodiagnostic kits and microfluidic testing instruments suitable for national conditions. They are generally suitable for various types of biochemical testing, immune testing, and testing of clinical diseases such as tumors. It can also be used in biomedicine, food safety and environmental testing.

The company has established an international cutting-edge R&D team and established cooperative relationships with institutions such as Wuhan National Laboratory of Optoelectronics, Wuhan University School of Basic Medicine, Wuhan Institute of Physics and Mathematics, Chinese Academy of Sciences, and Industrial Technology Research Institute of Huazhong University of Science and Technology, and continues to improve the team. self-research and development capabilities.

Vision: to detect diseases early and serve national health;
Mission: Committed to the innovation of point-of-care medical technology;
Core values: quality, professionalism, precision.

Wuhan Xinsheng Biotechnology Co., Ltd. masters the core technology of microfluidic chips, freeze-dried reagent beads and highly integrated optical, mechanical and electrical integration technology, and is committed to the development of testing instruments and microfluidic reagent chips for the majority of primary medical institutions.